Verily Life Sciences Stories May 19, 2020
Verily Life Sciences Stories March 26, 2020
Verily Life Sciences Stories March 15, 2020
Verily Life Sciences Stories March 13, 2020
The United States this afternoon declared a national emergency to better respond to COVID-19. During that press conference, President Trump and officials announced that Google was building a screening website to help with increased coronavirus testing. It has since emerged that what’s actually being developed is much more limited in scope.
Verily Life Sciences Stories January 23, 2020
Verily Life Sciences Stories January 9, 2020
Verily Life Sciences Stories February 25, 2019
Verily Life Sciences Stories February 6, 2019
Verily Life Sciences Stories February 1, 2019
Verily Life Sciences Stories January 18, 2019
FDA clears ECG feature on Verily Study Watch for medical research
Verily has a number of ongoing hardware projects from smart contact lenses to miniaturized continuous glucose monitors. Alphabet’s health division is also working on a Study Watch that was just granted ECG clearance by the FDA.
Verily Life Sciences Stories January 3, 2019
Verily Life Sciences Stories December 19, 2018
Technology has the potential to revolutionize healthcare over the coming years with Google internally spinning up a health division, while Alphabet has Verily. The latter today announced a strategic partnership with Walgreens on multiple projects to help patients with chronic conditions, and lower the cost of care.
Verily Life Sciences Stories November 16, 2018
One of Verily’s first projects was to make contact lenses that could detect glucose levels from teardrops. Less invasive than fingertip blood pricks for people living with diabetes, the Alphabet company and partner Alcon today announced that it is putting that project “on hold” due to the diabetes premise not being suitable.
Verily Life Sciences Stories August 14, 2018
In recent years, more and more startups have worked to disrupt traditional industries by leveraging technology and big data. Oscar was founded in 2012 to improve health insurance, and today it received a $375 million investment from Alphabet.
Verily Life Sciences Stories May 11, 2018
Verily Life Sciences Stories May 6, 2018
In 2015, President Obama announced the Precision Medicine Initiative to research individualized health care. Today, that All of Us program is officially launching and open for enrollment. With several components, Verily will be working on storing and organizing data for researchers.
Verily Life Sciences Stories February 27, 2018
Verily might be entering the health insurance market according to a new report this morning. Alphabet’s health division would not become an insurer, but rather work with existing ones and other partners to lower patient costs.
Verily Life Sciences Stories February 19, 2018
Verily Life Sciences Stories September 6, 2017
Back in July, a report revealed that Verily Life Sciences made an investment and built a lab for cancer detection startup Freenome at its campus. The Alphabet division has now revealed that the lab and offices are a part of the Verily Partner Space to foster collaboration with “pioneering start-ups.”
Verily Life Sciences Stories July 24, 2017
Verily Life Sciences Stories July 14, 2017
Verily Life Sciences Stories May 9, 2017
As part of its broader research into life sciences, Verily is tackling mental health by using technology to allow for earlier diagnosis and intervention. However, the Alphabet division has lost a major hire, with Dr. Thomas Insel departing.
Verily Life Sciences Stories April 19, 2017
Following last week’s announcement of the Study Watch, Verily is starting its four-year study to quantify good health with biometric data. In better understanding health, Baseline hopes to ultimately prevent diseases, as the Alphabet division continues work on other health gadgets.
Verily Life Sciences Stories April 14, 2017
Verily Life Sciences Stories September 28, 2016
While Google is rumored to be prepping up to two new in-house made Android Wear smartwatches — which may or may not be featured in next week’s event — a spinoff of Alphabet‘s former Google X named Verily is still actively working on its health-tracking watch (via MIT Technology Review), which is slowly advancing towards being a finished product…
Verily Life Sciences Stories August 1, 2016
It doesn’t seem that long ago when putting tiny machines into people’s bodies to cure or manage diseases was the stuff of science-fiction, but bioelectronics is a real – if very new – field of medicine. Alphabet’s Verily Life Sciences (formerly Google Life Sciences) and pharma company GSK are teaming up to invest $715M in the tech over the next seven years.
Bioelectronic medicine is a relatively new scientific field that aims to tackle a wide range of chronic diseases using miniaturised, implantable devices that can modify electrical signals that pass along nerves in the body, including irregular or altered impulses that occur in many illnesses. GSK has been active in this field since 2012 and believes certain chronic conditions such as arthritis, diabetes and asthma could potentially be treated using these devices …
Verily Life Sciences Stories July 1, 2016
The goal of last year’s Alphabet re-org was to effectively turn Google’s many research divisions into startups that make profitable products and services. To better incentivize executives and employees, a new report (via Bloomberg) says that Alphabet is implementing a new type of stock compensation whose value is tied to the performance of each company.
Verily Life Sciences Stories April 13, 2016
There has been quite a bit of press surrounding the behind-the-scenes aspect of Alphabet companies over recent weeks, mainly centered around Nest and Tony Fadell. Earlier today, it was reported that Fadell appeared at Google’s all-hands meeting two-weeks ago to address the stream of negative press. In addition to Fadell defending Nest, Re/code now reports that executive Sergey Brin also defended the company’s life science unit, Verily, at the meeting.
Verily Life Sciences Stories March 9, 2016
According to a recent FCC filling, Alphabet’s Life Sciences wing Verily has recently developed a new “Connectivity Bridge” for use in clinical studies. The device is capable of collecting and syncing medical information of people participating in clinical studies, allowing Google to continue to improve its efforts in healthcare.
Verily Life Sciences Stories December 7, 2015
Now that the Alphabet restructuring is kicking into gear, the company today has renamed its experimental health care branch. The branch was originally named Google Life Sciences, but from here on out will be known as “Verily.” The goals of Verily are identical to Life Sciences and the only thing that’s really changing is the name.